Experience

    • Due to the sensitive nature of Mr. Rubin’s confidential work counseling companies on FDA/FTC compliance matters, and handling non-public investigations, only a portion of his representative matters can be publicly disclosed.
  • Mergers & Acquisitions –Regulatory Due Diligence

    • Carestream Dental, a Clayton, Dubilier & Rice portfolio company and leading provider of dental technology, in the $600 million carve-out sale of its Scanning Technology business to Envista, a leading global dental products company.
    • The Carlyle Group in its investment in Resonetics, a leader in micro-manufacturing for the medical device and diagnostics equipment industries, valuing the company at approximately $2.25 billion.
    • The Carlyle Group in its strategic growth investment and acquisition of a majority stake in Saama, a leading AI-driven intelligent clinical cloud company that enables the life sciences industry to conduct faster and safer clinical developments and regulatory programs, valuing the company at up to $430 million.
    • Blackstone in its investment in Medable, the leading cloud platform for patient-centered clinical research, valuing Medable at $2.1 billion.
    • Pactiv Evergreen in its $380 million acquisition of Fabri-Kal, a U.S. manufacturer of foodservice and custom thermoformed plastic packaging solutions.
    • Clayton, Dubilier & Rice in its $6 billion acquisition and subsequent combination of Fort Dearborn and Multi-Color Corporation, to create the world's largest label solutions company.
    • Kelso & Company in its acquisition of Ferraro Foods, a specialty foodservice distributor.
    • Blackstone in its investment in Ginger, a leader in on-demand behavioral healthcare.
    • CPP Investments as lead investor in a $400 million Series C financing for insitro, a machine learning-driven drug discovery and development company.
    • Morgan Stanley Capital Partners in the sale of Manna Pro Products, a recognized leader in pet care to The Carlyle Group.
    • TPG Capital in the sale of Adare Pharmaceuticals, a leading specialty contract development and manufacturing organization, to Thomas H. Lee Partners and Frazier Healthcare Partners and the related separation of Adare’s Eosinophilic Esophagitis product into a TPG-backed entity.
    • Johnson & Johnson in its acquisition of TARIS, a biotechnology company specializing in the development of a novel drugs and delivery technologies for the treatment of cancer.
    • Allergan in its sale of Brazikumab to AstraZeneca and Zenpep to Nestle.
    • Prudential Financial in its $2.35 billion acquisition of Assurance IQ, a direct-to-consumer platform that transforms the buying experience for individuals seeking personalized health and financial wellness solutions.
    • Manna Pro, a manufacturer and marketer of pet care and nutrition products and a Morgan Stanley Capital Partners portfolio company, in its acquisition of Hero Pet Brands.
    • CPPIB in its investment in a Series B fundraising in Sana Biotechnology, a U.S.-based biotech company focused on creating and delivering engineered cells as treatments for disease.
  • FDA/FTC Compliance Matters

    • Numerous FDA and non-FDA regulated companies in confidential investigations.
    • A leading marketing company in settling advertising allegations with the FTC.
    • Numerous pharmaceutical, medical device, and consumer product companies in addressing complex FDA compliance issues.
    • Numerous investment banks and financial services companies in various hemp and CBD regulatory issues.
    • Medical Device Innovation Consortium, in preparing a comprehensive “cybersecurity playbook” for the medical device industry.

Education

  • University of Pennsylvania Law School, J.D.
  • University of Pennsylvania, Wharton School, B.S.